IBD Mount Sinai (@mountsinaiibd) 's Twitter Profile
IBD Mount Sinai

@mountsinaiibd

Everything about #IBD at @MountSinaiNYC. Investigating the genetic and immunologic factors associated with Crohn’s Disease and Ulcerative Colitis.

ID: 760933097126948864

linkhttp://labs.icahn.mssm.edu/cholab/ calendar_today03-08-2016 20:19:22

754 Tweet

959 Followers

53 Following

Mount Sinai Division of Gastroenterology (@mountsinaigi) 's Twitter Profile Photo

Wondering about the role of CT scans in diagnosing and managing ulcerative colitis? Get expert insights from Dr. Zoe Gottlieb, MD, as she breaks it down in this informative article. #UlcerativeColitis #MedicalImaging #WeFindAWay healthcentral.com/condition/ulce…

Jean-Frederic Colombel (@jeanfredericco1) 's Twitter Profile Photo

Last day of Adhesive Invasive E.coli (AIEC) 25 yrs meeting in NYC. Amazing crew of searchers from across the world. Talks about definition, epidemiology, clinical implication in CD, SA and cancer and therapeutic interventions. Thanks to Helmsley for sponsoring!

Last day of Adhesive Invasive E.coli (AIEC) 25 yrs meeting in NYC. 
Amazing crew of searchers from across the world. 
Talks about definition, epidemiology, clinical implication in CD, SA and cancer and therapeutic interventions.
Thanks to Helmsley for sponsoring!
Icahn School of Medicine at Mount Sinai (@icahnmountsinai) 's Twitter Profile Photo

Dr. Marla Dubinsky discusses a study that showed the efficacy of Mirikizumab in patients with ulcerative colitis, highlighting its durability via [email protected], which led to the approval of Mirikizumab by the FDA: mshs.co/3QUEo8Q Mount Sinai IBD Center Mount Sinai Department of Medicine

Dr. Marla Dubinsky discusses a study that showed the efficacy of Mirikizumab in patients with ulcerative colitis, highlighting its durability via <a href="/medresearchnews/">info@medicalresearch.com</a>, which led to the approval of Mirikizumab by the FDA: mshs.co/3QUEo8Q

<a href="/MSHS_IBDCenter/">Mount Sinai IBD Center</a> <a href="/DOMSinaiNYC/">Mount Sinai Department of Medicine</a>
IBD Mount Sinai (@mountsinaiibd) 's Twitter Profile Photo

FDA Approves Mirikizumab, a Promising Induction and Maintenance Therapy for Ulcerative Colitis. Offers new option with improved quality of life for patients with moderate-to-severely active disease mountsinai.org/about/newsroom…

IBD Mount Sinai (@mountsinaiibd) 's Twitter Profile Photo

🎄✨ Sending festive cheers from Mount Sinai IBD! 🏥❤️ Wishing our incredible patients, dedicated healthcare researchers and professionals, and supportive community a Christmas filled with comfort, joy, and moments of well-deserved rest. 🌟🎁 #MountSinaiIBD

🎄✨ Sending festive cheers from Mount Sinai IBD! 🏥❤️ Wishing our incredible patients, dedicated healthcare researchers and professionals, and supportive community a Christmas filled with comfort, joy, and moments of well-deserved rest. 🌟🎁 #MountSinaiIBD
Mount Sinai Division of Gastroenterology (@mountsinaigi) 's Twitter Profile Photo

So honored to host Tine Jess for our 17th Annual Joanna & David B Sachar International Award/Visiting Professorship in #IBD. Tine Jess visit is a momentous occasion for our division. We are incredibly grateful to learn from, and collaborate with, one of the best in the world!

So honored to host <a href="/DrTineJess/">Tine Jess</a> for our 17th Annual Joanna &amp; David B Sachar International Award/Visiting Professorship in #IBD. <a href="/DrTineJess/">Tine Jess</a> visit is a momentous occasion for our division. We are incredibly grateful to learn from, and collaborate with, one of the best in the world!
Rachel Levantovsky, PhD (@rlevantovsky) 's Twitter Profile Photo

I am so thrilled that our study defining mechanisms of #PerianalFistula in #Crohns disease is now out in Med by Cell Press . Thank you to Judy Cho + team, Mount Sinai IBD Center MountSinai Pathology SinaiMSTP , and the patients who made this possible doi.org/10.1016/j.medj…

Rachel Levantovsky, PhD (@rlevantovsky) 's Twitter Profile Photo

Med by Cell Press Judy Cho Mount Sinai IBD Center MountSinai Pathology SinaiMSTP With directly sampled fistulous tracts ( MountSinai Pathology ), a diverse patient cohort (Mount Sinai IBD Center , Colleen Chasteau, Ujunwa Korie, Diana Paguay), & layered multi-omic approaches we identified key contributors to fistula pathogenesis with therapeutic potential

<a href="/MedCellPress/">Med by Cell Press</a> <a href="/JudyCho7/">Judy Cho</a> <a href="/MSHS_IBDCenter/">Mount Sinai IBD Center</a> <a href="/MountSinai_Path/">MountSinai Pathology</a> <a href="/SinaiMSTP/">SinaiMSTP</a> With directly sampled fistulous tracts ( <a href="/MountSinai_Path/">MountSinai Pathology</a> ), a diverse patient cohort (<a href="/MSHS_IBDCenter/">Mount Sinai IBD Center</a> , Colleen Chasteau, Ujunwa Korie, Diana Paguay),  &amp; layered multi-omic approaches we identified key contributors to fistula pathogenesis with therapeutic potential
Lipschultz Precision Immunology Institute (@sinaiimmunol) 's Twitter Profile Photo

We're THRILLED to congratulate Matthew D. Park, Ph.D. on being named one of Forbes 30 under 30 in Healthcare 🥳!!! Check out his recent paper in Science Magazine on aging and cancer below, and his Forbes Under 30 profile >>> forbes.com/profile/matthe… science.org/doi/10.1126/sc…